ID   VKORL_RAT               Reviewed;         176 AA.
AC   Q6TEK3;
DT   12-APR-2005, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   29-MAY-2024, entry version 103.
DE   RecName: Full=Vitamin K epoxide reductase complex subunit 1-like protein 1;
DE            Short=VKORC1-like protein 1;
DE            EC=1.17.4.4 {ECO:0000269|PubMed:23928358};
GN   Name=Vkorc1l1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=14765194; DOI=10.1038/nature02214;
RA   Rost S., Fregin A., Ivaskevicius V., Conzelmann E., Hoertnagel K.,
RA   Pelz H.-J., Lappegard K., Seifried E., Scharrer I., Tuddenham E.G.D.,
RA   Mueller C.R., Strom T.M., Oldenburg J.;
RT   "Mutations in VKORC1 cause warfarin resistance and multiple coagulation
RT   factor deficiency type 2.";
RL   Nature 427:537-541(2004).
RN   [2]
RP   TISSUE SPECIFICITY, FUNCTION, CATALYTIC ACTIVITY, ACTIVITY REGULATION, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=23928358; DOI=10.1074/jbc.m113.457119;
RA   Hammed A., Matagrin B., Spohn G., Prouillac C., Benoit E., Lattard V.;
RT   "VKORC1L1, an enzyme rescuing the vitamin K 2,3-epoxide reductase activity
RT   in some extrahepatic tissues during anticoagulation therapy.";
RL   J. Biol. Chem. 288:28733-28742(2013).
CC   -!- FUNCTION: Involved in vitamin K metabolism. Can reduce inactive vitamin
CC       K 2,3-epoxide to active vitamin K, and may contribute to vitamin K-
CC       mediated protection against oxidative stress. Plays a role in vitamin
CC       K-dependent gamma-carboxylation of Glu residues in target proteins.
CC       {ECO:0000269|PubMed:23928358}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=[protein]-disulfide + H2O + phylloquinone = 2,3-
CC         epoxyphylloquinone + [protein]-dithiol; Xref=Rhea:RHEA:13817,
CC         Rhea:RHEA-COMP:10593, Rhea:RHEA-COMP:10594, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15759, ChEBI:CHEBI:18067, ChEBI:CHEBI:29950,
CC         ChEBI:CHEBI:50058; EC=1.17.4.4;
CC         Evidence={ECO:0000269|PubMed:23928358};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=[protein]-disulfide + phylloquinol = [protein]-dithiol +
CC         phylloquinone; Xref=Rhea:RHEA:57744, Rhea:RHEA-COMP:10593, Rhea:RHEA-
CC         COMP:10594, ChEBI:CHEBI:18067, ChEBI:CHEBI:28433, ChEBI:CHEBI:29950,
CC         ChEBI:CHEBI:50058; EC=1.17.4.4;
CC         Evidence={ECO:0000269|PubMed:23928358};
CC   -!- ACTIVITY REGULATION: Inhibited by warfarin (coumadin)
CC       (PubMed:23928358). Warfarin locks VKORC1 in both redox states into the
CC       closed conformation (By similarity). {ECO:0000250|UniProtKB:Q6TEK8,
CC       ECO:0000269|PubMed:23928358}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000305|PubMed:23928358}; Multi-pass membrane protein
CC       {ECO:0000305|PubMed:23928358}.
CC   -!- TISSUE SPECIFICITY: Detected in lung, liver, testis, and at lower
CC       levels in kidney and brain. {ECO:0000269|PubMed:23928358}.
CC   -!- SIMILARITY: Belongs to the VKOR family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY423048; AAR82918.1; -; mRNA.
DR   RefSeq; NP_976083.1; NM_203338.1.
DR   RefSeq; XP_008764222.1; XM_008766000.2.
DR   AlphaFoldDB; Q6TEK3; -.
DR   SMR; Q6TEK3; -.
DR   STRING; 10116.ENSRNOP00000024691; -.
DR   BindingDB; Q6TEK3; -.
DR   PhosphoSitePlus; Q6TEK3; -.
DR   jPOST; Q6TEK3; -.
DR   PaxDb; 10116-ENSRNOP00000024691; -.
DR   GeneID; 399684; -.
DR   KEGG; rno:399684; -.
DR   AGR; RGD:1303249; -.
DR   CTD; 154807; -.
DR   RGD; 1303249; Vkorc1l1.
DR   VEuPathDB; HostDB:ENSRNOG00000000901; -.
DR   eggNOG; ENOG502S4E7; Eukaryota.
DR   HOGENOM; CLU_105471_0_0_1; -.
DR   InParanoid; Q6TEK3; -.
DR   OrthoDB; 68850at2759; -.
DR   PhylomeDB; Q6TEK3; -.
DR   Reactome; R-RNO-6806664; Metabolism of vitamin K.
DR   PRO; PR:Q6TEK3; -.
DR   Proteomes; UP000002494; Chromosome 12.
DR   Bgee; ENSRNOG00000018291; Expressed in frontal cortex and 2 other cell types or tissues.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; ISS:UniProtKB.
DR   GO; GO:0048038; F:quinone binding; IEA:UniProtKB-KW.
DR   GO; GO:0047057; F:vitamin-K-epoxide reductase (warfarin-sensitive) activity; IDA:UniProtKB.
DR   GO; GO:0034599; P:cellular response to oxidative stress; ISS:UniProtKB.
DR   GO; GO:0017187; P:peptidyl-glutamic acid carboxylation; ISS:UniProtKB.
DR   GO; GO:0042373; P:vitamin K metabolic process; IDA:UniProtKB.
DR   CDD; cd12917; VKOR_euk; 1.
DR   Gene3D; 1.20.1440.130; VKOR domain; 1.
DR   InterPro; IPR012932; VKOR.
DR   InterPro; IPR038354; VKOR_sf.
DR   InterPro; IPR042406; VKORC1/VKORC1L1.
DR   PANTHER; PTHR14519:SF5; VITAMIN K EPOXIDE REDUCTASE COMPLEX SUBUNIT 1-LIKE PROTEIN 1; 1.
DR   PANTHER; PTHR14519; VITAMIN K EPOXIDE REDUCTASE COMPLEX, SUBUNIT 1; 1.
DR   Pfam; PF07884; VKOR; 1.
DR   SMART; SM00756; VKc; 1.
PE   1: Evidence at protein level;
KW   Disulfide bond; Endoplasmic reticulum; Membrane; Oxidoreductase; Quinone;
KW   Redox-active center; Reference proteome; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..176
FT                   /note="Vitamin K epoxide reductase complex subunit 1-like
FT                   protein 1"
FT                   /id="PRO_0000191673"
FT   TOPO_DOM        1..13
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q6TEK8"
FT   TRANSMEM        14..36
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:Q6TEK8"
FT   TOPO_DOM        37..87
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000250|UniProtKB:Q6TEK8"
FT   TRANSMEM        88..102
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:Q6TEK8"
FT   TOPO_DOM        103..107
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q6TEK8"
FT   TRANSMEM        108..135
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:Q6TEK8"
FT   TOPO_DOM        136..138
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000250|UniProtKB:Q6TEK8"
FT   TRANSMEM        139..160
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:Q6TEK8"
FT   TOPO_DOM        161..176
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q6TEK8"
FT   BINDING         87
FT                   /ligand="(S)-warfarin"
FT                   /ligand_id="ChEBI:CHEBI:87744"
FT                   /evidence="ECO:0000250|UniProtKB:Q6TEK8"
FT   BINDING         142
FT                   /ligand="phylloquinone"
FT                   /ligand_id="ChEBI:CHEBI:18067"
FT                   /evidence="ECO:0000250|UniProtKB:Q6TEK8"
FT   BINDING         146
FT                   /ligand="(S)-warfarin"
FT                   /ligand_id="ChEBI:CHEBI:87744"
FT                   /evidence="ECO:0000250|UniProtKB:Q6TEK8"
FT   BINDING         146
FT                   /ligand="phylloquinone"
FT                   /ligand_id="ChEBI:CHEBI:18067"
FT                   /evidence="ECO:0000250|UniProtKB:Q6TEK8"
FT   DISULFID        50..58
FT                   /note="Redox-active"
FT                   /evidence="ECO:0000250|UniProtKB:Q6TEK8"
FT   DISULFID        139..142
FT                   /note="Redox-active"
FT                   /evidence="ECO:0000250|UniProtKB:Q6TEK8"
SQ   SEQUENCE   176 AA;  19779 MW;  0B713A95CB3B0E00 CRC64;
     MAAPVLLRVS VPRWERVARY AVCAAGILLS IYAYHVEREK ERDPEHRALC DLGPWVKCSA
     ALASRWGRGF GLLGSIFGKD GVLNQPNSVF GLIFYILQLL LGMTASAVAA LVLMTSSIVS
     VVGSLYLAYI LYFVLKEFCI ICVTTYVLNF LLLIINYKRL VYLNEAWKRQ LQPKED
//
